(Q34489346)

2 August 2017

1 reference

title

Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth (English)

1 reference

2 August 2017

Sanduleanu S

1

1 reference

2 August 2017

Jonkers D

2

1 reference

2 August 2017

de Bruïne A

3

1 reference

2 August 2017

Hameeteman W

4

1 reference

2 August 2017

Stockbrügger RW

5

1 reference

2 August 2017

1 November 2001

1 reference

Digestive and Liver Disease

2 August 2017

1 reference

2 August 2017

33

1 reference

2 August 2017

707-719

1 reference

2 August 2017

8

1 reference

Ultrastructure of a neuroendocrine complex in oxyntic mucosa of normal human stomach

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Structure and function of endocrine cells in the oxyntic (acid-secreting) mucosa of human stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The achlorhydria-carcinoid sequence: role of gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Proliferation of endocrine cells in the rat stomach caused by drug-induced achlorhydria

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Serum gastrin levels during long-term omeprazole treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Qualitative Studies of Gastric Endocrine Cells in Patients Treated Long-term with Omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. A study in the oxyntic mucosa of duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Session 6: Is Hypergastrinaemia Dangerous to Man?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastrin-physiological and pathophysiological role: clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Considerations for long-term use of proton-pump inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Personal review: is profound acid inhibition safe?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Influence of gastric pH on gastric and jejunal flora

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Bacterial overgrowth as a consequence of reduced gastric acidity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Bacterial colonization and nitrite concentration in the achlorhydric stomachs of patients with primary hypogammaglobulinaemia or classical pernicious anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The microflora of the postoperative stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Hydrogen (H2) breath test and gastric bacteria in acid-secreting subjects and in achlorhydric and postgastrectomy patients before and after antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The microflora of the gastric juice after Billroth I and Billroth II partial gastrectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori and non-Helicobacter pylori bacterial flora in gastric mucosal and tumour specimens of patients with primary gastric lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effects of acid suppression on microbial flora of upper gut.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Relationship between gastric secretion and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Relationship of the intestinal bacterial flora to absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Bacterial overgrowth syndrome without "blind loop": A cause for malnutrition in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

An investigation of the endogenous formation of apparent total N-nitroso compounds in conventional microflora and germ-free rats

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

N-nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Nitrates, nitrites and gastric cancer in Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Mechanisms of gastric carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Nitrosation of amines by stimulated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori and peptic ulceration: histopathological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The relationships between chronic gastritis and gastric acid secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori gastritis and gastric physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori infection and chronic gastric acid hyposecretion

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Muscarinic receptors in gastric mucosa are increased in peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Campylobacter pylori and duodenal ulcers: the gastrin link

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of a Campylobacter pylori protein on acid secretion by parietal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

A reappraisal of the nature and significance of chronic atrophic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The Sydney System: histological division

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The Sydney System: epidemiology and natural history of chronic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The Sydney System: a new classification of gastritis. Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Are there three types of Helicobacter pylori gastritis?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Observer variation in the assessment of chronic gastritis according to the Sydney system.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Recognizing atrophy: another step toward a classification of gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The effect of environmental pH on the proton motive force of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Influence of pH on metabolism and urease activity of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of omeprazole on duodenal ulcer-associated antral gastritis andHelicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Morphology and function of the parietal cells after proximal selective vagotomy in duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23--27 years' follow-up examinations

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Changing Patterns of Helicobacter pylori Gastritis in Long-Standing Acid Suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Review article: the development of atrophic gastritis--Helicobacter pylori and the effects of acid suppressive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Omeprazole and accelerated onset of atrophic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Omeprazole and accelerated onset of atrophic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Omeprazole and accelerated onset of atrophic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Lack of effect of acid suppression therapy on gastric atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Helicobacter pylori and atrophic gastritis: importance of the cagA status

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Atrophic Gastritis and Intestinal Metaplasia in Helicobacter pylori Infection: The role of CagA status

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Cigarette Smoking and Other risk Factors for progression of Precancerous Stomach Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Mechanism of gastric mucosal damage induced by ammonia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980050-5

7 January 2021

10.1016/S1590-8658(01)80050-5

Identifiers

DOI

1 reference

2 August 2017

1 reference